#Pandemic #Cannabis Innovation: New Cannabis/Hemp Products Hit Market (OTC: $CSUI) (TSX: $RIV.TO) (OTC: $CNPOF) (TSX: $ALEF.TO) (OTC: $ALEAF) (OTC: $HEMP)
Point Roberts WA, Delta, BC – May 12, 2020 - Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a special news report on how the cannabis industry continues to expand and innovate during the pandemic, featuring Cannabis Suisse Corp. (OTC:CSUI).
Cannabis companies being deemed “essential” during the COVID-19 Pandemic, in addition to booming online sales, has resulted in renewed vitality to an industry coming off of an unstable year. Companies are not only looking at ways to better serve communities and customers safely, but are also launching new products and using this downtime for R & D and license expansion.
A great example of this, Cannabis Suisse Corp. (OTC:CSUI) just announced the addition of a new retail product to its variety of offerings. They range from helping consumers grow their own cannabis plants to a revolutionary, pure base CBD vape liquid. During the global crisis, the Company is not ceasing to create and deliver innovative ideas.
From the news: “Since the cannabis industry has developed, the brands on the market have been working extensively on improving the production quantity and the quality of pre-rolled joints. They have become so popular among users of recreational cannabis due to their small size and compactness. It’s a rather easy-to-use product that delivers an enjoyable and unique experience anytime people use it.
The simplicity of the joints is simply royal, which is no surprise due to Cannabis Suisse Corp. partnering up with RAW, who are known for their ‘best of the best’ rolling papers. RAW comes unbleached, it contains neither chalk, nor dyes, nor flammable additives. These papers just immerse smokers into the experience of using the finest strains of V1 cannabis. Wrapped in unrefined natural paper, the joints give customers a unique smoking experience with a gourmet taste.
The V1 is special for its ability to relax users without sedation and to relieve them without intoxication. The V1 strain is an immensely powerful CBD plant and is guaranteed to contain no less than 20% CBD along with no more than 0.85% THC. It is delicious to smoke having a natural hint of lemon and lime flavors and an enjoyable fresh aftertaste.
The V1 strains are derived from recreational strains and are one of the best-selling products on the market. Over the last few years the V1 has surely become one of the most exciting CBD strains containing around 90% Sativa and 10% Indica. The V1 plant is known to have low yield however it is widely used for therapeutic purposes. People who tried consuming it in different ways report having a feeling of peace and relaxation. It is easy to recognize by hard compact flowerheads. Apart from the crystal appearance, the V1 also has a strong specific scent. V1 will be the main strain for ALPINE CANNABIS CBD tobacco production.
Cannabis users from California, Colorado, Arizona, Oregon, and Washington spent around $36 million in pre-rolled joints only in May of 2019 according to the report introduced by BDS Analytics. (https://bdsa.com/wp-content/uploads/2019/07/CPI-Template-May.pdf). Apart from that, in the end of 2019 the Swiss government finally removed the 25% tobacco tax which was a significant event for the country. In five years from now, Europe is expected to become the largest legal cannabis market in the world. In 2019, the industry there has grown more than in the last six years together.
As always, CSUI’s pre-rolled CBD joints are wrapped in premium quality paper from RAW. They will be made only of quality fresh buds (no leaves, of course) cultivated with non-pesticide fertilizers and biological control agents. The new product line of handmade pre-rolled CBD joints will have no additives. They are free from pesticides, fungicides, heavy metals or nicotine. Natural hemp is always manually harvested and selected with care. No post-harvest wash processing of the cannabis applies. The final product contains all the natural terroir it is supposed to have. This is the Cannabis Suisse finest ready-to-smoke weed product ever cultivated using proprietary growing methods in fully contained facilities in Zurich, Switzerland.
Cannabis Suisse is the first company in Switzerland to offer this uniquely blended fusion of organic cones with optimally boosted CBD content. The THC level has been naturally kept under 1%. CBD flower pre-rolled joints are an all-natural alternative to CBD oil products. They offer pain- relieving, calming and anti-inflammatory properties.
Any cannabis consumer knows how difficult it is to choose a pre-rolled joint. There are lots of doubts whether a package has really as much cannabis flower as the manufacturer indicated, how joints will be wrapped and glued, how they will smolder. Alpine Cannabis buyers will never encounter such problems. The company maintains its work at a high-quality standard. The trademark gives consumers 100% confidence they will get premium quality goods. The quality of the pre-rolled joints is not going to be different from the quality of cannabis buds in bags where consumers can make sure what they are buying. Moreover, upon trying and realizing the convenience of the joints, consumers will return for them over and over again.
Each step of creation process is taken by masters. The Company is happy to present the highest quality and best priced CBD flower pre-rolled joints for the Swiss retail market. The V1 strain is currently growing and the first retail supplies of this product are expected to be ready for selected vendors in July 2020.
CSUI has forward-looking plans to expand outside Switzerland developing customized products. Some European countries like Germany, Denmark, Malta, Greece and Italy discussed the possibility of creating a completely regulated cannabis market by 2028. Furthermore, Luxembourg intends to introduce a regulated market for adult use of cannabis by 2023.
Based on all of the above advantages of the Company’s product, the situation in the European market and forthcoming amendments to the legislation, the Company’s decision to launch a new product line is more than an appropriate and timely one. An investment in this production will pay off for the company in the nearest future, increase the income and make the brand recognizable. In our forecasts, to get a minimum of 400,000 CHF 12 months after the start of sales. CSUI’s pre- rolled joints will become another business card of the Company’s trademark. The product will occupy this niche in the market, crowding out other similar products.”
Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) is also looking to bring new innovative products to market having recently announced a C$2 million investment in Dynaleo Inc., an Edmonton-based company focused on white-label manufacturing edible cannabis gummies for the Canadian market. Through this investment in what the Company anticipates may become a leading industrial scale Canadian gummies manufacturer, Canopy Rivers believes it is capitalizing on a significant opportunity in what is currently an underserved and underdeveloped segment of the cannabis market. Once Dynaleo receives the required licencing from Health Canada, it expects to begin operating its 27,000 sq. ft. purpose-built facility with the goal of producing enough gummies to take a sizable bite out of the projected edibles market.
"We believe that Dynaleo is positioned to become a market leader in cannabis edibles manufacturing in Canada," said Narbé Alexandrian, President & CEO, Canopy Rivers. "In the gummies market specifically, we see a significant supply and demand imbalance and a move towards outsourcing products to leading manufacturers. We think Dynaleo's manufacturing capabilities, combined with its capable management team, position it to help close this supply gap in the short term and become a trusted manufacturer of cannabis edibles in the long term."
When Cannabis 2.0 launched in Canada, regulatory uncertainties around the gummy format led many license holders to focus on other edible cannabis formats, with only some licensed producers investing in the infrastructure to produce gummies. As a result of this, initial market observations suggest that the demand for edibles is significantly ahead of supply, with limited product availability and consistently high out-of-stock rates relative to other products.
Headset data from mature U.S. markets, combined with Deloitte's projection that Canada's edibles market could be worth $1.6 billion annually, indicates that there is an opportunity for increased gummy production in Canada. In Colorado and California, Headset reports that gummies were the top selling edible product, accounting for 55% and 56% of edible cannabis sales respectively in 2019. Assuming that Canadians emulate these consumption habits, Canadian licensed producers may not yet have the production capacity or partnerships to fulfill this demand.
"On top of helping Canada's licensed producers close the supply gap, we also believe that Dynaleo will play a role in expanding the total addressable market for cannabis products, with market research indicating that new consumers are more likely to enter the cannabis market through edibles than other products," added Alexandrian.
Another competitor looking to enter the EU marketplace, Aleafia Health Inc.’s (TSX: ALEF) (OTC: ALEAF) indirect subsidiary, Emblem Germany GmbH, recently announced formally submitting its application to German regulators for EU Good Manufacturing Practices certification.
The Company’s newly licensed Paris Facility has been purpose built to meet EU-GMP certification requirements, pharmaceutical-grade production’s highest standard, and as a result, provides wide access to global markets. The application, if successful, would allow the Company’s Paris Facility to produce and export EU-GMP certified cannabis products to the European Union.
Cannabis production operations commenced on May 6, 2020 at the Paris Facility Phase II expansion, only three business days following receipt of the amended Health Canada license. Aleafia Health indirectly owns 60 percent of Emblem Germany, by way of a joint-venture between Emblem and German pharmaceutical wholesaler and logistics company, Acnos Pharma GmbH. It is difficult to ascertain the timeline for securing certification, but the Company intends to continue preparing for an eventual facility inspection.
Aleafia Health and Acnos’ senior management are directing the effort and have previously led the build-out, certification and operation of multiple EU-GMP certified pharmaceutical production facilities in The Netherlands, Germany and North America.
Later this month, Acnos is expected to complete a new state-of-the-art pharmaceutical production and supply chain facility in Aachen Brand, Germany. It contains a dedicated cannabis distribution hub that Acnos owns and Emblem Germany will operate, allowing the Company to commence sales upon receipt of necessary German export and import permits.
“The state-of-art expansion of the Paris Facility, purpose built to meet EU-GMP standards, creates a unique competitive advantage with significant barriers to entry,” said Aleafia Health CEO, Geoffrey Benic. “We look forward to leveraging the skillsets of our strong partner Acnos Pharma along with our management team’s in-house EU-GMP expertise.”
“The near completion of our international cannabis distribution center along with Emblem’s Paris Facility Phase II expansion licence are breakthrough milestones toward our goal to achieve a EU-GMP Licence and receiving Emblem-produced cannabis oil products in Germany," said Maximillian Claudel, Acnos Co-Owner and Managing Director, Emblem Germany.
Hemp, Inc. (OTC: HEMP), a global leader in the industrial hemp industry with bi-coastal processing centers, including the 85,000 square foot multipurpose industrial hemp processing facility on 9 acres in Spring Hope, NC, a 55,000 square foot state-of the art local processing center in White City, Oregon, a 500-acre hemp growing Veteran Village Kins Community in Golden Valley, Arizona, two model “Small Family Hemp Farms” in North Carolina and Arizona, a pre-roll blending manufacturing facility in Las Vegas, NV, and a 5,000 square-foot retail store in Kingman, Arizona, is also bringing new products to market having announced the launch of the King of Hemp™ website where Bruce Perlowin’s King of Hemp™ pre-rolls, made from premium, smokable hemp flower, are available for purchase.
Hemp, Inc. CEO, Bruce Perlowin’s King of Hemp™ pre-roll line offers high-end products that are an effective and flavorful, smokable alternative to cigarettes and other hemp consumption methods. The newly launched King of Hemp™ pre-rolls are compliant with the 2018 Farm Bill, federal regulations, and regulations in the markets where they are available for purchase. The King of Hemp™ pre-rolls can be purchased individually or in packs of 6. Each pre-roll is 1 gram and does not exceed 0.3% THC.
King of Hemp™ pre-rolls use A and B hemp colas which are derived from Pre-98 OG Bubba Kush, one of the top selling cultivars on the market. The strain, rich soil and climate lend themselves to these colas being among the highest quality buds, positioning them to be some of the best tasting for consumption.
The Company’s new website for its King of Hemp™ line (www.kingofhempusa.com) also has CBD oil tinctures available for purchase. The tinctures are available in two flavors, Natural and Peppermint, and contain full-spectrum hemp oil extracted from the flowers and leaves of hemp plants sustainably sourced from Colorado. They are also compliant with the regulations created by the Colorado Department of Agriculture in regards to industrial hemp. The tinctures contain .3% or less THC and are compliant with the 2018 Farm Bill.
“The King of Hemp™ pre-rolls were well received during our soft launch and have been lauded as one of the best smokes out there. We crafted them with great care -- from concept to the cola, and now with our official launch,” said Hemp, Inc. CEO, Bruce Perlowin. “We really wanted to give this product line the time and respect it needed to be brought to market. I’m very excited for hemp enthusiasts, CBD patients and first-time hemp smokers to enjoy the King of Hemp™ pre-roll line.”
As the hemp/CBD and cannabis industry continues to see aggressive online sales and demand in new international markets there will be significant opportunity for great new product innovation. This is especially true as the industry continues to remain dependent on online sales which forces businesses to be much more aware of consumer feedback and product preferences.
About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: this news article featuring CSUI is a paid for article on Investorideas.com as part of a monthly news and social media program. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Contact Investorideas.com
800 665 0411
